🇺🇸 FDA
Patent

US 8957188

Antibodies that bind GalNAc1-3Gal, pharmaceutical compositions and methods of using same

granted A61KA61K51/1045A61P

Quick answer

US patent 8957188 (Antibodies that bind GalNAc1-3Gal, pharmaceutical compositions and methods of using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K51/1045, A61P, A61P35/04